The Global Fund
The Global Fund to Fight AIDS, Tuberculosis and Malaria is a Geneva-based multilateral financing institution that mobilizes and deploys donor capital as grants across 100+ countries to combat HIV/AIDS, tuberculosis, and malaria and to strengthen health systems.
- Company typePrivate
- Founded2002
- HeadquartersGeneva, Switzerland
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What The Global Fund does
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing institution headquartered in Geneva, Switzerland, founded in 2002. It mobilizes donor capital through periodic replenishment conferences and deploys it as grants to more than 100 countries to combat HIV/AIDS, tuberculosis, and malaria, while strengthening underlying health systems. The organization is governed by a multi-stakeholder Board and operates through a partnership model in which governments, civil society, the private sector, and affected communities co-design and co-implement programs via Principal Recipients that include national agencies, NGOs, and multilateral bodies such as WHO, UNICEF, UNDP, and PEPFAR.
Its core operational outputs are grant allocations of up to US$4 billion annually, pooled procurement and distribution of health products (antiretrovirals, insecticide-treated bed nets, TB medicines, diagnostic kits, and increasingly advanced therapeutics such as Gilead's lenacapavir for HIV PrEP), and capacity-building in disease surveillance, laboratory networks, and community health workforces. The organization invests roughly US$150 million annually in digital surveillance infrastructure and has upgraded 186 labs and trained 70,000+ community health workers across 34 countries as of 2024. Supporting technical assets include the Data Explorer and Data Service platforms providing open programmatic and financial data, and event-based surveillance, wastewater monitoring, and digital disease reporting tools deployed across implementing countries.
The Global Fund does not generate revenue from product sales; it raises funds through sovereign donor replenishments (UK, Germany, Sweden, US via PEPFAR), private philanthropy (Gates Foundation, GSK, ViiV Healthcare), corporate campaigns (Apple/(RED), with cumulative contributions exceeding US$270 million since 2006), and increasingly through co-financing arrangements with World Bank and Gavi (US$2 billion) and a proposed blended finance instrument projected to add up to US$1 billion annually by 2033. Its current Eighth Replenishment cycle (2026-2028) is underway following a documented funding crisis that triggered $1.5 billion in approved grant allocation cuts, alongside new program launches in lenacapavir rollout, rapid TB testing across 13 countries, and regional partnerships with Africa CDC and Asian Development Bank.
The Global Fund firmographics
Firmographics- Name
- The Global Fund
- Legal name
- The Global Fund to Fight AIDS, Tuberculosis and Malaria
- Website
- https://theglobalfund.org
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- The Global Fund to Fight AIDS, Tuberculosis and Malaria is a Geneva-based multilateral financing institution that mobilizes and deploys donor capital as grants across 100+ countries to combat HIV/AIDS, tuberculosis, and malaria and to strengthen health systems.
- Ownership category
- akta.pro rank
The Global Fund industry classification
Industry- Product category
- Global Health Financing
- NAICS
- Grantmaking Foundations (813211), Grantmaking and Giving Services (81321), Voluntary Health Organizations (813212)
- SIC
- Federal & Federally-Sponsored Credit Agencies (6111), International Affairs (9721)
- akta.pro primary industry
- Global Health Financing Mechanisms (HLAJAKAC)
- akta.pro secondary industries
- Grantmaking & Philanthropic Funds (Institutional Donors) (BPADAOAB), Trust Funds & Multi-Donor Pooled Funds (BPADAOAE), Global Health Financing Mechanisms & Pooled Funds (HLAJAOAC), Public Health Financing, Budgeting & Grants Management (HLAJAMAC)
Keywords
Where The Global Fund is headquartered
LocationHeadquarters
- HQ city
- Geneva
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
The Global Fund business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Supply Chain, Personnel, Infrastructure, Others
Revenue model
- Government Donor Replenishments: The Global Fund mobilizes resources through periodic replenishment conferences where donor governments commit funding for multi-year cycles (e.g., Eighth Replenishment). Major donors include Sweden, Germany, UK, and others.
- Private Sector Philanthropy and Corporate Partnerships: Apple partnered with (RED) for a campaign donating $5 per qualifying Apple Pay purchase up to $3 million to the Global Fund. Corporate donors provide both financial contributions and in-kind support.
- Blended Finance and Concessional Loans: A proposed hybrid model combining grants for the poorest countries with concessional loans for middle-income countries, projected to generate up to $1 billion annually in new financing by 2033.
- Co-Financing Partnerships with Multilateral Institutions: Partnerships with World Bank, Gavi, and the Global Financing Facility involving co-financing agreements such as $2 billion with Gavi and The Global Fund plus up to $410 million from philanthropic partners.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
The Global Fund product offering
Product offeringCore offering
The Global Fund is an international financing institution that mobilizes and disburses grants to fight AIDS, tuberculosis, and malaria. It invests up to US$4 billion annually across more than 100 countries, channeling donor funds to governments, NGOs, and civil society organizations that implement HIV treatment, TB diagnosis and care, malaria prevention (including distribution of insecticide-treated nets), and broader health system strengthening programs.
Product overview
The Global Fund operates as a financing organization rather than a traditional product company. Its core 'product' is a grant funding mechanism that invests up to US$4 billion annually to defeat AIDS, TB, and malaria. Supporting offerings include the Data Explorer and Data Service tools for accessing investment and impact data, a Sourcing & Management platform for health product procurement, and regular Results Reports documenting outcomes. The organization unites global partners to find health solutions and take them to scale worldwide.
Differentiator
Problem solved
Functional benefit
Products and services
- Global Fund Grants Program
Quantifiable outcome
- 70 million lives saved through the Global Fund partnership
- +8 more outcomes
Companies that use The Global Fund
Customer profileNamed customers14 records
Segments5 records
Ideal customer profiles4 records
The Global Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
The Global Fund partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- World Bank GroupcoreThe World Bank Group partnered with the Global Fund through $2 billion co-financing agreements and up to $410 million from the Global Financing Facility and Health System Transformation and Resilience Fund. The UHC Knowledge Hub was launched in Tokyo as a joint initiative.
- Gavi, the Vaccine AlliancecoreGavi and the Global Fund entered into $2 billion co-financing agreements to support health programs in low- and middle-income countries.
- Ministry of Foreign Affairs of South KoreaminorSouth Korea's Ministry of Foreign Affairs co-hosts the annual Korea-Global Fund Procurement Forum with the Global Fund to help Korean bio-pharmaceutical and medical device companies access the Global Fund's procurement market.
- PEPFAR (U.S. President's Emergency Plan for AIDS Relief)corePEPFAR collaborates with the Global Fund on HIV prevention programs, including the expanded access to lenacapavir reaching up to 3 million people by 2028. Both organizations coordinate distribution infrastructure for HIV prevention drugs.
- UNICEFcoreUNICEF partners with the Global Fund on health product distribution, including malaria bed net campaigns such as the distribution of 16 million bed nets in Sudan in partnership with Sudan's Federal Ministry of Health.
- Gilead SciencescoreGilead Sciences provides lenacapavir (its twice-yearly injectable HIV prevention drug) at no profit through PEPFAR and The Global Fund, with voluntary licensing agreements with six generic manufacturers for large-scale rollout expected in 2027.
- Clinton Health Access Initiative (CHAI)coreCHAI collects data on HIV services across sub-Saharan Africa and Asia, providing evidence on program outcomes and funding crisis impacts in partnership with the Global Fund.
- Africa CDCcoreThe Global Fund and Africa CDC joined forces in 2026 to advance stronger, self-reliant health systems across Africa, intensifying collaboration with regional partners.
- Asian Development Bank (ADB)coreADB and the Global Fund entered a US$2 million co-financing agreement to support the Philippines in advancing universal health care and expanding access to health services.
- AppleminorApple partnered with (RED) on a donation campaign supporting the Global Fund through Apple Pay transactions, with a cap of $3 million. Apple and (RED) have contributed over $270 million since 2006.
- (RED)minor(RED) partners with Apple and the Global Fund on fundraising campaigns, including a limited-time campaign donating $5 per qualifying Apple Pay purchase up to $3 million during December 2025.
- Amref Health AfricacoreAmref Health Africa supports over 11,000 community health workers to fight TB and malaria in Kenya, in partnership with the Global Fund.
- UnitaidcoreUnitaid co-invests with the Global Fund in new health products, including the New Nets Project (US$33 million each from 2018-2022) for new insecticide-treated nets and the Expert Review Panel for Diagnostics.
- CO 100% LIFE (Ukraine)coreA local HIV community network in Ukraine that organizes courier delivery of antiretrovirals and other medicines to homes during COVID-19, supported by Global Fund grants.
- ROOTS Africa (Zimbabwe)minorLed by Beatrice Savadye, ROOTS Africa provides door-to-door care in Zimbabwe including food parcels, travel authorizations, and antiretroviral treatments during COVID-19 lockdowns.
Scale indicators18 records
Recent moves6 records
Expansion highlights6 records
The Global Fund competitors and assessment
Company assessmentDirect peers
- Gavi, the Vaccine Alliance: Gavi is the most directly comparable multilateral financing mechanism, pooling donor funds and channeling them to low-income countries for immunization programs. It shares the replenishment model, Geneva-area base, co-financing partnerships with The Global Fund and the World Bank, and identical stakeholder governance (governments, civil society, private sector, foundations).
- Unitaid: Unitaid is a Geneva-based multilateral financing mechanism that co-invests with The Global Fund on innovative health products (e.g., the $33M-per-year New Nets Project). It is a direct peer in pooled-fund grantmaking for global health product access, though smaller in scale and focused on upstream innovation rather than at-scale deployment.
- PEPFAR (U.S. President's Emergency Plan for AIDS Relief): PEPFAR is the single largest bilateral HIV/AIDS financing mechanism and a co-funder of lenacapavir rollout alongside The Global Fund. It is comparable as a pooled fund targeting the same disease vertical in overlapping countries, with similar supply chain and treatment-on-therapy scale metrics.
- Bill & Melinda Gates Foundation: The Gates Foundation is the largest private philanthropic funder of global health, matching GSK and ViiV contributions and co-investing with The Global Fund on HIV/TB/malaria. Comparable as a pooled funder operating across the same disease verticals, though structured as a foundation rather than a multilateral replenishment vehicle.
- Clinton Health Access Initiative (CHAI): CHAI is a core implementation partner of The Global Fund, providing data and programmatic support across sub-Saharan Africa and Asia. Comparable as a pooled funder/implementer operating in HIV/TB/malaria service delivery, though smaller and operating more through technical assistance than direct grants.
Broad incumbents
- WHO (World Health Organization): WHO is a core technical and normative partner of The Global Fund and a much larger incumbent in global health governance. It is comparable in mandate (HIV, TB, malaria) but operates as the standard-setting, surveillance-coordinating UN agency rather than a financing mechanism, making it a broader incumbent with overlapping rather than competing scope.
- World Bank Group: The World Bank is a co-financing partner ($2B co-financing agreements) and a much broader multilateral development institution. It is comparable in operating scale and pooled-fund mechanisms for health in low-income countries, but its mandate extends well beyond health into infrastructure, education, and broader development finance.
- UNICEF: UNICEF is a core implementation partner (e.g., 16M bed net campaign in Sudan) and a comparable UN-affiliated organization with global health supply chain operations. It is a broader incumbent that serves overlapping beneficiaries (mothers, children) but covers a much wider mandate including education and child protection.
Emerging players
- Africa CDC: Africa CDC is a regional pooled-fund and coordination entity that signed a joint partnership with The Global Fund in May 2026 to strengthen self-reliant health systems. Comparable as a pooled health-financing/coordination mechanism, though geographically scoped to Africa and earlier-stage in financial scale.
- Global Financing Facility (GFF): The GFF is a World Bank-hosted pooled fund for women's, children's, and adolescents' health that channels up to $410M through the Health System Transformation and Resilience Fund with The Global Fund. Comparable as a pooled financing mechanism in overlapping low-income country footprints, though focused on RMNCH rather than HIV/TB/malaria specifically.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
The Global Fund social profiles
Digital presenceThe Global Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Global Fund leadership team
Management profileNumber of profiles
Profiles8 records
The Global Fund funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Global Fund M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Global Fund
What does The Global Fund do?
The Global Fund is an international financing institution that mobilizes and disburses grants to fight AIDS, tuberculosis, and malaria. It invests up to US$4 billion annually across more than 100 countries, channeling donor funds to governments, NGOs, and civil society organizations that implement HIV treatment, TB diagnosis and care, malaria prevention (including distribution of insecticide-treated nets), and broader health system strengthening programs.
Is The Global Fund a public or private company?
The Global Fund is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Global Fund founded?
The Global Fund was founded in 2002. It employs 501 to 1,000 people.
Where is The Global Fund based?
The Global Fund is headquartered in Geneva, Switzerland, in the Europe region.
How does The Global Fund make money?
Four revenue lines are on record. Government Donor Replenishments are the primary driver. The others are private Sector Philanthropy and Corporate Partnerships, blended Finance and Concessional Loans and co-Financing Partnerships with Multilateral Institutions.
Who are The Global Fund's main competitors?
Direct peers on record are Gavi, the Vaccine Alliance, Unitaid, PEPFAR (U.S. President's Emergency Plan for AIDS Relief), Bill & Melinda Gates Foundation and Clinton Health Access Initiative (CHAI). Broad incumbents are WHO (World Health Organization), World Bank Group and UNICEF. Emerging players are Africa CDC and Global Financing Facility (GFF).
Does The Global Fund have an API?
No public API is recorded for The Global Fund.
What industry is The Global Fund in?
The Global Fund's product category is Global Health Financing. Its primary akta.pro industry code is HLAJAKAC, Global Health Financing Mechanisms, with a secondary code of BPADAOAB, Grantmaking & Philanthropic Funds (Institutional Donors). Its NAICS code is 813211 and its SIC code is 6111.